|
CANX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.175000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.065700E-02 |
| Normal-vs-Stage2 |
7.031000E-01 |
| Normal-vs-Stage3 |
3.699000E-01 |
| Normal-vs-Stage4 |
3.102800E-01 |
| Stage1-vs-Stage2 |
3.667600E-01 |
| Stage1-vs-Stage3 |
6.112100E-02 |
| Stage1-vs-Stage4 |
1.598220E-01 |
| Stage2-vs-Stage3 |
3.004200E-01 |
| Stage2-vs-Stage4 |
2.703800E-01 |
| Stage3-vs-Stage4 |
4.690000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.536600E-01 |
| Normal-vs-AfricanAmerican |
1.588200E-01 |
| Normal-vs-Asian |
6.924200E-01 |
| Caucasian-vs-AfricanAmerican |
6.421800E-01 |
| Caucasian-vs-Asian |
3.798000E-01 |
| AfricanAmerican-vs-Asian |
4.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.346100E-02 |
| Normal-vs-Female |
2.854200E-01 |
| Male-vs-Female |
1.979790E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.253600E-01 |
| Normal-vs-Extreme_Weight |
1.595530E-02 |
| Normal-vs-Obese |
5.510600E-01 |
| Normal-vs-Extreme_Obese |
4.232400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.489400E-01 |
| Normal_Weight-vs-Obese |
8.774600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.223000E-01 |
| Extreme_Weight-vs-Obese |
1.107790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.388000E-01 |
| Obese-vs-Extreme_Obese |
2.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.085400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.154600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.126430E-02 |
| Normal-vs-Age(81-100Yrs) |
1.672590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.825800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.059800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.842000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.844700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.571620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.426800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.035100E-04 |
| Normal-VS-Type2 PRCC |
1.116650E-01 |
| Normal-VS-KIRP CIMP |
8.433800E-01 |
| Normal-VS-Unclassified PRCC |
3.928000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.389390E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.706580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.363600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.155800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.421000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.258000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.339200E-01 |
| Normal-vs-N1 |
3.100000E-01 |
| Normal-vs-N2 |
1.907240E-01 |
| N0-vs-N1 |
2.414400E-01 |
| N0-vs-N2 |
7.720400E-02 |
| N1-vs-N2 |
3.948800E-01 |
|
|
